propranolol has been researched along with vitamin k semiquinone radical in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (66.67) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (16.67) | 29.6817 |
| 2010's | 1 (16.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ | 1 |
| D'Amico, G; Pagliaro, L; Pasta, L | 1 |
| Fujita, S; Fukushima, Y; Ishida, R; Suzuki, T; Usui, T | 1 |
| Maggi, GC | 1 |
| Condat, B | 1 |
2 trial(s) available for propranolol and vitamin k semiquinone radical
| Article | Year |
|---|---|
Propranolol prevents first gastrointestinal bleeding in non-ascitic cirrhotic patients. Final report of a multicenter randomized trial. The Italian Multicenter Project for Propranolol in Prevention of Bleeding.
Topics: Adolescent; Adult; Aged; Ascites; Clinical Trials as Topic; Female; Follow-Up Studies; Gastrointestinal Hemorrhage; Humans; Liver Cirrhosis; Male; Meta-Analysis as Topic; Middle Aged; Multicenter Studies as Topic; Prognosis; Propranolol; Random Allocation; Retrospective Studies; Risk Factors; Vitamin K | 1989 |
A randomised controlled trial of propranolol for the prevention of initial bleeding in cirrhotic patients with portal hypertension. Preliminary results. The Italian Multicenter Project for Propranolol in the Prevention of Bleeding.
Topics: Aged; Female; Gastrointestinal Hemorrhage; Hepatitis B Surface Antigens; Humans; Hypertension, Portal; Liver Cirrhosis; Male; Middle Aged; Propranolol; Randomized Controlled Trials as Topic; Survival Analysis; Vitamin K | 1989 |
4 other study(ies) available for propranolol and vitamin k semiquinone radical
| Article | Year |
|---|---|
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship | 2012 |
Effect of vitamin K3 on the first-pass elimination of propranolol in the rat.
Topics: Animals; Cytochrome P-450 Enzyme System; In Vitro Techniques; Infusions, Parenteral; Kinetics; Male; Microsomes, Liver; Portal Vein; Propranolol; Rats; Rats, Inbred Strains; Vitamin K | 1985 |
[Prevention and general therapy of coronary insufficiency].
Topics: Aged; Aging; Angina Pectoris; Anticoagulants; Coronary Disease; Ethanolamines; Humans; Middle Aged; Nitroglycerin; Propranolol; Vitamin K | 1971 |
[Jaundice and portal cavernoma].
Topics: Antineoplastic Agents; Cholestasis, Extrahepatic; Cohort Studies; Diagnosis, Differential; Follow-Up Studies; Hemangioma, Cavernous; Humans; Hydroxyurea; Jaundice; Male; Middle Aged; Portal Vein; Propranolol; Radiography, Abdominal; Retrospective Studies; Risk Factors; Time Factors; Tomography, X-Ray Computed; Vascular Neoplasms; Vasodilator Agents; Vitamin K | 2006 |